NASDAQ:AFIB

Acutus Medical Insider Trades

$9.06
-0.53 (-5.53 %)
(As of 09/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.62
▼
$9.46
50-Day Range
$9.06
▼
$16.70
52-Week Range
$8.62
▼
$34.35
Volume483,095 shs
Average Volume335,480 shs
Market Capitalization$313.55 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Acutus Medical (NASDAQ:AFIB) Insider Buying and Selling Activity

24.40% of Acutus Medical's shares are owned by company executives, directors and other insiders. Over the past twelve months, Acutus Medical insiders have purchased shares 1 time(s), totalling $14,999,992.00.

Insider Buying and Selling by Quarter


Acutus Medical (NASDAQ AFIB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/19/2021Orbimed Advisors LlcDirectorBuy1,071,428$14.00$14,999,992.00  
(Data available from 1/1/2013 forward)
speech bubbles
speech bubbles











Acutus Medical (NASDAQ:AFIB) Insider Trade Frequently Asked Questions

Who is on Acutus Medical's Insider Roster?

The list of insiders at Acutus Medical includes Orbimed Advisors Llc.Learn more on AFIB's insiders

What percentage of Acutus Medical stock is owned by insiders?

24.40% of Acutus Medical stock is owned by insiders. Learn more on AFIB's insider holdings

Which Acutus Medical insiders have been buying company stock?

The following insider purchased Acutus Medical stock in the last 24 months: Orbimed Advisors Llc ($14,999,992.00).

How much insider buying is happening at Acutus Medical?

Insiders have purchased a total of 1,071,428 Acutus Medical shares in the last 24 months for a total of $14,999,992.00 bought.

This page was last updated on 9/24/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.